Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

The association between benzodiazepine use and healthcare utilization in patients with dementia

FY 2018-19

Summary
Background: Canada’s aging population poses challenges to healthcare systems, partly due to a rising incidence of dementia. These persons have twice the acute hospital use of elders without dementia. Benzodiazepines (BZDs) are widely prescribed to patients with dementia, despite guidelines recommending against their use due to adverse side effects, risks and little evidence for their effectiveness. Adverse BZD-linked events may prompt consultations with the healthcare system, which can be distressing for the patient and costly to the system. It is thus essential to understand the implications of BZD use for dementia patients’ interactions with healthcare systems. Objective: The objective of this research is to evaluate the association between BZD use and healthcare utilization in persons with dementia. Proposed Methods: Data for this cross-sectional study will be collected from the INSPQ database (exhaustive repository of health information for Quebecois population aged 65+). Those with dementia will be identified and divided into exposure groups based on their prescription status March 31, 2018: 1) chronic BZD users, 2) acute BZD users and 3) non-users. Healthcare utilization data (number of emergency visits, number and length of hospitalizations, transfer to long-term care) and mortality in the following three months will then be collected. We will conduct linear regression analyses to compare each utilization component and mortality between groups. Multivariate analyses will account for confounders (previous utilization, comorbidities, chronic pain, S.E.S., sex and age). Significance: This research is expected to inform policy, guidelines and physician decision-making for BZD prescriptions for patients with dementia to minimize unnecessary healthcare utilization.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406329
Name
Margo-Dermer Eva
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The association between benzodiazepine use and healthcare utilization in patients with dementia
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Benzodiazepine; Dementia; Healthcare Utilization
Abstract
Background: Canada’s aging population poses challenges to healthcare systems, partly due to a rising incidence of dementia. These persons have twice the acute hospital use of elders without dementia. Benzodiazepines (BZDs) are widely prescribed to patients with dementia, despite guidelines recommending against their use due to adverse side effects, risks and little evidence for their effectiveness. Adverse BZD-linked events may prompt consultations with the healthcare system, which can be distressing for the patient and costly to the system. It is thus essential to understand the implications of BZD use for dementia patients’ interactions with healthcare systems. Objective: The objective of this research is to evaluate the association between BZD use and healthcare utilization in persons with dementia. Proposed Methods: Data for this cross-sectional study will be collected from the INSPQ database (exhaustive repository of health information for Quebecois population aged 65+). Those with dementia will be identified and divided into exposure groups based on their prescription status March 31, 2018: 1) chronic BZD users, 2) acute BZD users and 3) non-users. Healthcare utilization data (number of emergency visits, number and length of hospitalizations, transfer to long-term care) and mortality in the following three months will then be collected. We will conduct linear regression analyses to compare each utilization component and mortality between groups. Multivariate analyses will account for confounders (previous utilization, comorbidities, chronic pain, S.E.S., sex and age). Significance: This research is expected to inform policy, guidelines and physician decision-making for BZD prescriptions for patients with dementia to minimize unnecessary healthcare utilization.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Margo-Dermer, Eva
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~